Two years of patient data reveal real-world efficacy of COVID-19 treatments

The COVID-19 pandemic created a real-life experiment that demanded health care providers nationwide rapidly stand up clinics to administer an evolving offering of monoclonal antibody treatments that—while initially proven safe and effective in clinical trials and approved under federal emergency use authorization—had never been tested at such a scale.